<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001635'>Heart failure</z:hpo> is characterized by several abnormalities of sympathetic cardiac activity that can be assessed by 123I metaiodobenzylguanidine single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (MIBG SPECT) </plain></SENT>
<SENT sid="1" pm="."><plain>This technique may be useful in the clinical management of <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Abnormal MIBG uptake has been demonstrated to be a predictor of <z:hpo ids='HP_0011420'>death</z:hpo> and arrhythmic events in <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients with a prognostic power incremental to that of conventional risk markers; it may also be useful to identify patients at low risk of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> despite current guideline indications for an implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) or patients at high risk for <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> not fulfilling <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> indications </plain></SENT>
<SENT sid="3" pm="."><plain>This review will focus on the clinical applications of MIBG SPECT in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo>, on the basis of the most recent evidence </plain></SENT>
</text></document>